Thromboxane A2 receptor signaling

No Pathway Network information available for Thromboxane A2 receptor signaling

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Thromboxane A2 receptor signaling SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Proteus syndromeEnrichmentAKT12.60
2Hypomagnesemia 4, renalEnrichmentEGF2.60
3Nephrolithiasis/osteoporosis, hypophosphatemic, 2EnrichmentNHERF12.60
4Asthma-related traits 1EnrichmentPTGDR2.60
5Ventricular tachycardia, familialEnrichmentGNAI22.60
6Immunodeficiency 62EnrichmentARHGEF12.60
7Immunodeficiency 82 with systemic inflammationEnrichmentSYK2.60
8Bleeding disorder, platelet-type, 13EnrichmentTBXA2R2.60
9Myopia 26, x-linked, female-limitedEnrichmentARR32.60
10Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmiaEnrichmentGNB52.60
11Cowden syndrome 6EnrichmentAKT12.60
12Pigmented nodular adrenocortical disease, primary, 4EnrichmentPRKACA2.60
13Immunodeficiency 97 with autoinflammationEnrichmentPIK3CG2.60
14Immunodeficiency 22EnrichmentLCK2.60
15Cardioacrofacial dysplasia 1EnrichmentPRKACA2.60
16Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomaliesEnrichmentRHOA2.60
17Intellectual developmental disorder, autosomal dominant 42EnrichmentGNB12.60
18Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomaliesEnrichmentRHOA2.60
19ColitisEnrichmentSYK2.60
20Bleeding diathesis due to thromboxane synthesis deficiencyEnrichmentTBXA2R2.60
21Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndromEnrichmentRAC12.60
22Egf-related primary hypomagnesemia with intellectual disabilityEnrichmentEGF2.60
23Pituitary adenoma 4, acth-secretingEnrichmentGNAI22.30
24Intellectual developmental disorder, autosomal dominant 48EnrichmentRAC12.30
25HypophosphatemiaEnrichmentNHERF12.30
26Fibrolamellar carcinomaEnrichmentPRKACA2.30
27HypopituitarismEnrichmentGNAI22.30
28Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmiaEnrichmentGNB52.30
29ArthritisEnrichmentSYK2.30
30Dominant hypophosphatemia with nephrolithiasis or osteoporosisEnrichmentNHERF12.30
31Cerebral visual impairmentEnrichmentGNB12.30
32Autosomal dominant non-syndromic intellectual disabilityEnrichmentGNB1, RAB11A2.16
33Neonatal nephrocutaneous inflammatory syndromeEnrichmentEGFR2.12
34Developmental and epileptic encephalopathy 31bEnrichmentDNM12.12
35Neonatal inflammatory skin and bowel diseaseEnrichmentEGFR2.12
36Cerebral malariaEnrichmentICAM12.00
37Alzheimer disease 2EnrichmentNOS31.90
38Developmental and epileptic encephalopathy 31aEnrichmentDNM11.90
39Pre-eclampsiaEnrichmentNOS31.90
40Cowden syndrome 1EnrichmentEGFR1.83
41Hemihyperplasia, isolatedEnrichmentRHOA1.83
42Breast adenocarcinomaEnrichmentAKT11.83
43Lung squamous cell carcinomaEnrichmentEGFR1.83
44Squamous cell carcinoma, head and neckEnrichmentEGFR1.76
45Lennox-gastaut syndromeEnrichmentDNM11.70
46HypothyroidismEnrichmentGNB11.70
47Ellis-van creveld syndromeEnrichmentPRKACA1.65
48Neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesEnrichmentRAC11.65
49Adult hepatocellular carcinomaEnrichmentEGF1.65
50Cowden syndromeEnrichmentAKT11.65
51Stroke, ischemicEnrichmentNOS31.61
52NephrolithiasisEnrichmentNHERF11.61
53Ovarian cancerEnrichmentAKT1, EGFR1.58
54Immune deficiency diseaseEnrichmentSYK1.56
55Leukemia, acute lymphoblasticEnrichmentGNB11.56
56Myelodysplastic syndromeEnrichmentGNB11.56
57Lung non-small cell carcinomaEnrichmentEGFR1.56
58MeningiomaEnrichmentAKT11.53
59Lip and oral cavity carcinomaEnrichmentEGFR1.53
60Chromosome 1p36 deletion syndromeEnrichmentPRKCZ1.49
61Stereotypic movement disorderEnrichmentDNM11.49
62Lung cancer susceptibility 3EnrichmentEGFR1.46
63GliosarcomaEnrichmentEGFR1.40
64Isolated congenital microcephalyEnrichmentRAB11A1.40
65Alzheimer disease, familial, 1EnrichmentNOS31.38
66Hypertension, essentialEnrichmentNOS31.38
67Cleft palate, isolatedEnrichmentGNB11.38
68Giant cell glioblastomaEnrichmentEGFR1.38
69Arteriovenous malformations of the brainEnrichmentEGFR1.33
70Attention deficit-hyperactivity disorderEnrichmentGNB51.27
71MalariaEnrichmentICAM11.25
72Jeune thoracic dystrophyEnrichmentGRK21.22
73StrabismusEnrichmentGNB11.18
74Asphyxiating thoracic dystrophyEnrichmentGRK21.17
75Bladder cancerEnrichmentEGFR1.15
76Lung cancerEnrichmentEGFR1.11
77Short-rib thoracic dysplasia 1 with or without polydactylyEnrichmentGRK21.10
78Severe combined immunodeficiencyEnrichmentLCK1.10
79DystoniaEnrichmentGNB11.07
80Cerebral palsyEnrichmentGNB11.03
81West syndromeEnrichmentDNM10.98
82Hereditary breast carcinomaEnrichmentAKT10.98
83Undetermined early-onset epileptic encephalopathyEnrichmentDNM10.88
84Primary ovarian insufficiencyEnrichmentNOS30.86
85Breast cancerEnrichmentAKT10.76
86Colorectal cancerEnrichmentAKT10.71
87Congenital nervous system abnormalityEnrichmentGNB50.63
88Nervous system diseaseEnrichmentGNB50.63
89Autism spectrum disorderEnrichmentGNB10.62
90MicrocephalyEnrichmentGNB10.57
91Inherited cancer-predisposing syndromeEnrichmentEGFR0.55

Loading...
Loading...
Loading...